CORT Stock Analysis: Buy, Sell, or Hold?
CORT - Corcept Therapeutics Inc.
$83.12
0.21 (0.25%)
▲
5d:
+13.35%
30d:
+42.57%
90d:
+158.3%
WAIT
LOW Confidence
Analysis Updated: Jun 15, 2026 12:00 AM ET
Earnings: Jul 30, 2026
Get Alerted When CORT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: CORT is 16.6% above its trading range ($71.29). Market expects -7.6% annual growth, but current price leaves little margin for error. While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: CORT is 16.6% above its trading range ($71.29). Market expects -7.6% annual growth, but current price leaves little margin for error. While momentum could continue, risk/reward favors waiting for a pullback.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$121.47
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$75.42
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: CORT is currently trading at $83.12, which is considered extended relative to its 30-day fair value range of $53.19 to $71.29. From a valuation perspective, the stock is trading at a discount (Forward PE: 33.2) compared to its historical average (42.1). Remarkably, the market is currently pricing in an annual earnings decline of 7.6% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, CORT is in a strong uptrend. The price is approaching resistance at $84.79. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: CORT has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CORT is in a strong uptrend. The price is approaching resistance at $84.79. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: CORT has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$53.19 -
$71.29
Company Quality Score
58/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
47.6%
Protect Your Profits
CORT is technically overbought (RSI 86). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price significantly overextended (+16.6% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($88.00)
- WARNING: Recommendation downgraded due to 16.6% overvaluation
Trading Range Analysis
30-Day Trading Range
$53.19 -
$71.29
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$68.85
Resistance Level
$84.79
Current Trend
Strong Uptrend
Technical data as of
Jun 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
33.23
Wall Street Target
$88.00
(+6.1%)
Revenue Growth (YoY)
4.9%
Earnings Growth (YoY)
-21.6%
Profit Margin
6.2%
Valuation Discount vs History
-7.6% cheaper
PE vs Historical
33.2 vs 42.1
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-7.6%
(market-implied from PE analysis)
1-Year Target
$76.61
(-8%)
2-Year Target
$70.79
(-15%)
3-Year Target
$65.41
(-21%)
3-Yr Target (if PE normalizes)
(PE: 33→42)
$82.86
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 33.2, Growth: 411.8%)
$279.82
(+238%)
Base:
(SPY PE: 21.9, Growth: 411.8%)
$184.58
(+123%)
Bear:
(PE: 18.6, Growth: 411.8%)
$156.89
(+89%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (96x PE), but valuation improves significantly next year (33x PE) as earnings recover.
Forward PE: 96.15 | Forward EPS (Implied): $0.86
Bull Case
$100.11
(+21%)
Analyst growth 15.0%, PE expands to 101.0
Base Case
$82.91
(0%)
Market implied 0.0%, PE stable at 96.2
Bear Case
$63.43
(-24%)
Severe decline -15.0%, PE contracts to 86.5
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 33.2 to 42.1
Stabilization Target:
$105.04
(+26.7%)
PE Expansion Potential:
+26.7%
Share & Embed Analysis
Last updated: June 15, 2026 4:33 PM ET
Data refreshes hourly during market hours. Next update: 5:32 PM
Data refreshes hourly during market hours. Next update: 5:32 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CORT showing a specific setup today?
Insider Activity (6 Months)
1
Buys
6
Sells
Net
INSIDERS SELLING
Recent Transactions
William Guyer
SELL
20000 shares
2026-04-07
Joseph K Belanoff
SELL
26198 shares
2026-03-25
William Guyer
SELL
11767 shares
2026-03-20
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1029 | 64 BUY |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$84 | 53 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$9 | 50 HOLD |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$297 | 51 HOLD |
Advanced CORT Option Strategies
Professional options setups generated by AI based on today's CORT price and gamma walls.
